IGFBP3 and breast cancer: A pooled data analysis of 17 prospective studies has further confirmed the positive association between circulating IGF1 and breast cancer risk, which was not substantially modified by IGFBP3 and did not differ markedly by menopausal status but seemed to be confined to ER-positive tumors (9).